Is Ekso Bionics Holdings, Inc. (EKSO) A Good Stock To Buy Now?
In this article you are going to find out whether hedge funds think Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) is a good investment right now.
Ekso Bionics Holdings Inc. (EKSO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sabby Capital Hal Mintz | 398,800 | $1,153 | -21% | 0.17% |
| 2. | Renaissance Technologies Jim Simons | 17,600 | $51 | -78% | 0% |
| 3. | 13,700 | $40 | +1% | 0% | |
| 4. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.52 | 100,000 | Director | 400,825 | 2018-05-23 | Filing | |
| $1.50 | 100,000 | Director | 300,825 | 2018-05-23 | Filing | |
| $1.27 | 20,000 | Director | 48,224 | 2017-09-14 | Filing | |
| $1.23 | 16,264 | Director | 16,264 | 2017-09-14 | Filing | |
| $1.13 | 15,000 | Officer, Director | 20,315 | 2017-09-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.74 | 5,330 | Officer, Director | 659,031 | 2022-06-22 | Filing | |
| $1.90 | 6,911 | Officer, Director | 648,762 | 2022-06-15 | Filing | |
| $1.76 | 6,597 | Officer, Director | 637,408 | 2022-05-24 | Filing | |
| $2.41 | 6,862 | Officer, Director | 628,406 | 2022-04-28 | Filing | |
| $2.62 | 4,043 | Officer | 73,815 | 2022-04-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 440,683 | $1,274 | 0% | |
| 2. | 167,645 | $484 | 0.06% | |
| 3. | 108,122 | $312 | 0% | |
| 4. | 106,739 | $309 | 0% | |
| 5. | 25,900 | $75 | 0% |
News See All
Should You Buy Ekso Bionics Holdings, Inc. (EKSO)?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Hedge Fund and Insider Trading News: Sahm Adrangi, Bernard Selz, Stryker Corporation (SYK), VBI Vaccines Inc (VBIV), and More
Kerrisdale Capital, the US hedge fund that made a public enemy of Neil Woodford after shorting two of his prominent holdings, is no longer making bets against companies backed by the embattled UK stock...
Billionaire Hedge Funds
